SPAGNOLO, Paolo
 Distribuzione geografica
Continente #
NA - Nord America 5.995
EU - Europa 2.886
AS - Asia 1.792
SA - Sud America 326
AF - Africa 31
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 5
Totale 11.040
Nazione #
US - Stati Uniti d'America 5.929
IT - Italia 1.118
GB - Regno Unito 664
CN - Cina 623
SG - Singapore 503
SE - Svezia 275
BR - Brasile 258
HK - Hong Kong 249
DE - Germania 191
UA - Ucraina 152
VN - Vietnam 123
RU - Federazione Russa 122
FI - Finlandia 98
TR - Turchia 85
NL - Olanda 57
KR - Corea 54
BG - Bulgaria 52
FR - Francia 50
IN - India 50
CA - Canada 43
AR - Argentina 34
ID - Indonesia 24
MX - Messico 22
BE - Belgio 16
PL - Polonia 15
BD - Bangladesh 13
IE - Irlanda 12
ZA - Sudafrica 12
CO - Colombia 10
EC - Ecuador 10
ES - Italia 10
AL - Albania 8
LT - Lituania 8
PK - Pakistan 8
IQ - Iraq 7
JP - Giappone 7
AT - Austria 6
CZ - Repubblica Ceca 6
PY - Paraguay 6
UZ - Uzbekistan 6
CH - Svizzera 5
EU - Europa 5
KE - Kenya 5
MA - Marocco 5
AZ - Azerbaigian 4
HR - Croazia 4
IL - Israele 4
IR - Iran 4
SA - Arabia Saudita 4
TW - Taiwan 4
AU - Australia 3
DK - Danimarca 3
GR - Grecia 3
LK - Sri Lanka 3
RO - Romania 3
TH - Thailandia 3
AE - Emirati Arabi Uniti 2
BO - Bolivia 2
DZ - Algeria 2
ET - Etiopia 2
JO - Giordania 2
MY - Malesia 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PE - Perù 2
SN - Senegal 2
VE - Venezuela 2
AD - Andorra 1
AM - Armenia 1
AO - Angola 1
CL - Cile 1
EG - Egitto 1
GE - Georgia 1
HU - Ungheria 1
JM - Giamaica 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MT - Malta 1
NP - Nepal 1
OM - Oman 1
PH - Filippine 1
PS - Palestinian Territory 1
PT - Portogallo 1
QA - Qatar 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
UY - Uruguay 1
Totale 11.040
Città #
Fairfield 686
Santa Clara 636
Woodbridge 506
Southend 450
Ashburn 430
Houston 361
Chandler 335
Jacksonville 327
Singapore 277
Seattle 257
Hong Kong 247
Dearborn 239
Ann Arbor 236
Cambridge 223
Wilmington 221
Nyköping 183
Hefei 171
Beijing 146
London 129
Milan 73
New York 63
Chicago 62
San Diego 62
Los Angeles 58
Naples 58
Modena 57
Eugene 52
Princeton 52
Rome 52
Sofia 51
Palermo 47
Helsinki 45
Seoul 41
Shanghai 40
Ho Chi Minh City 37
Council Bluffs 34
Hanoi 33
The Dalles 33
Buffalo 29
Dallas 28
Florence 27
São Paulo 27
Boardman 26
Salt Lake City 25
Turin 23
Falls Church 22
Moscow 22
Toronto 20
Izmir 19
San Francisco 19
Bari 18
Jakarta 18
Frankfurt am Main 17
Brussels 16
Columbus 15
Des Moines 15
Reggio Emilia 13
Tampa 13
Phoenix 12
Bologna 11
Pescara 11
Dublin 10
Warsaw 10
Belo Horizonte 9
Guangzhou 9
Holly 9
Indiana 9
Jinan 9
Long Branch 9
Seongnam 9
Amsterdam 8
Bremen 8
Brooklyn 8
Chennai 8
Dong Ket 8
Montreal 8
Norwalk 8
Redwood City 8
Stockholm 8
Tirana 8
Verona 8
Hounslow 7
Istanbul 7
Jersey City 7
Leawood 7
Mumbai 7
Munich 7
Napoli 7
Perugia 7
Ankara 6
Catania 6
Kunming 6
Lucca 6
Lusciano 6
Mexico City 6
Ottawa 6
Pioltello 6
Redondo Beach 6
Rimini 6
Tashkent 6
Totale 7.749
Nome #
Malattie infiltrative diffuse del polmone 1.066
Bronchoalveolar lavage and response to cyclophosphamide in scleroderma alveolitis. 386
Non-steroid agents for idiopathic pulmonary fibrosis 386
Structured reporting for fibrosing lung disease: a model shared by radiologist and pulmonologist 330
Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia (DIPNECH) Syndrome and Carcinoid Tumors With/Without NECH: A Clinicopathologic, Radiologic, and Immunomolecular Comparison Study. 322
Role Of The QFT-IT Assay For The Diagnosis Of Latent Tuberculosis Infection Among Adult Immigrants 271
Efficacy of hormonal suppression in a patient with chyluria due to lymphangioleiomyomatosis 260
Analysis of BTNL2 genetic polymorphisms in British and Dutch patients with sarcoidosis 258
Lung cancer in scleroderma: results from an Italian rheumatologic center and review of the literature. 253
Amyotrophic lateral sclerosis and sarcoidosis: a difficult differential diagnosis. 243
CARD15/NOD2 polymorphisms are associated with severe pulmonary sarcoidosis 240
Management of Idiopathic Pulmonary Fibrosis 236
Prevalence Of Subclinical Liver Fibrosis Among Patients With Idiopathic Pulmonary Fibrosis 236
HRCT Patterns Of Usual Interstitial Pneumonia In Rheumatoid Lung 236
Smoking-related interstitial lung disease 234
Environmental triggers and susceptibility factors in idiopathic granulomatous diseases. 225
CC chemokine receptor 5 gene polymorphisms in beryllium disease 223
Sarcoidosis: challenging diagnostic aspects of an old disease. 222
Management of idiopathic pulmonary fibrosis. 216
Association between Heat Shock Protein 70/Hom genetic polymorphisms and uveitis in patients with sarcoidosis 211
RHEUMATOID ARTHRITIS RELATED INTERSTITIAL LUNG DISEASE. RADIOLOGICAL PATTERNS AND CORRELATIONS WITH CLINICAL, SEROLOGICAL AND DEMOGRAPHIC FEATURES OF DISEASE 211
Accuracy of individual in the monitoring of long term change in pulmonary sarcoidosis as judge by serial HRCT data 208
The big clinical trials in idiopathic pulmonary fibrosis. 206
C-C chemokine receptor 2 and sarcoidosis: association with Lofgren's syndrome 205
A common haplotype of the C-C chemokine receptor 2 gene and HLA-DRB1*0301 are independent genetic risk factors for Löfgren’s syndrome 203
Genetic commonality between inflammatory bowel disease and sarcoidosis: the beginning of the end or the end of the beginning? 200
The complex interrelationships between chronic lung and liver disease: a review. 198
Idiopathic pulmonary fibrosis: diagnostic pitfalls and therapeutic challenges. 188
Genetic testing in diffuse parenchymal lung disease 185
Co-trimoxazole effect on human alveolar macrophages of AIDS patients 184
C-C chemokine receptor 5 gene variants in relation to lung disease in sarcoidosis 179
To BAL or not to BAL: is this a problem in diagnosing IPF? 176
Sarcoidosis HLA class II genotyping distinguishes differences of clinical phenotype across ethnic groups 174
BTNL2 allele associations with chronic beryllium disease in HLD-DPB1*Glu69-negative individuals 174
Chemokine gene polymorphisms in idiopathic anterior uveitis 174
Long-term macrolide treatment for chronic respiratory disease 172
Defining the clinical outcome status (COS) in sarcoidosis: results of WASOG Task Force 171
A Functional polymorphism in the CTGF promoter is associated with risk of systemic sclerosis 157
Genetic predisposition to sarcoidosis: another brick in the wall. 150
The role of bronchoalveolar lavage cellular analysis in the diagnosis of interstitial lung diseases 146
Recent advances in the Genetic of Sarcoidosis 145
Intracellular cytokine profiles ant T cell activation in pulmonary sarcoidosis 144
Malattie infiltrative diffuse del polmone 134
Primary endpoints in phase 3 clinical trials in idiopatic pulmonary fibrosis: one step at a time 132
Rare lung disease and orphan drug development 131
Increased mean lung density:another indipendent predictor of lung cancer? 129
The reply 128
New insights on COPD imaging via CT and MRI 124
Single-nucleotide polymorphisms in CCL2 gene are not associated with susceptibility to systemic sclerosis 106
Genetics of sarcoidosis 106
Sex differences in emphysema phenotype in smokers without airflow obstruction 101
Totale 11.095
Categoria #
all - tutte 43.442
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.442


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021652 0 0 0 0 0 128 86 150 35 127 82 44
2021/20221.048 28 178 105 59 30 50 60 38 116 64 171 149
2022/20231.049 134 110 71 87 130 126 31 129 124 26 44 37
2023/2024951 35 58 62 70 159 109 122 101 18 28 88 101
2024/20252.174 78 26 37 153 495 336 168 168 228 104 176 205
2025/20261.655 202 137 354 353 508 101 0 0 0 0 0 0
Totale 11.095